Adc Therapeutics SA (NYSE: ADCT) kicked off on Tuesday, up 6.30% from the previous trading day, before settling in for the closing price of $2.7. Over the past 52 weeks, ADCT has traded in a range of $1.05-$4.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1.38% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 8.89%. With a float of $77.65 million, this company’s outstanding shares have now reached $99.18 million.
In an organization with 265 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 90.97%, operating margin of -178.81%, and the pretax margin is -212.48%.
Adc Therapeutics SA (ADCT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adc Therapeutics SA is 21.71%, while institutional ownership is 61.51%. The most recent insider transaction that took place on Dec 11 ’24, was worth 304,500. In this transaction 10% Owner of this company bought 100,000 shares at a rate of $3.04, taking the stock ownership to the 15,666,731 shares. Before that another transaction happened on Dec 11 ’24, when Company’s 10% Owner bought 100,000 for $3.04, making the entire transaction worth $304,500. This insider now owns 13,145,712 shares in total.
Adc Therapeutics SA (ADCT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 8.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.36% during the next five years compared to 1.38% growth over the previous five years of trading.
Adc Therapeutics SA (NYSE: ADCT) Trading Performance Indicators
Take a look at Adc Therapeutics SA’s (ADCT) current performance indicators. Last quarter, stock had a quick ratio of 4.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.31 in one year’s time.
Technical Analysis of Adc Therapeutics SA (ADCT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.69 million. That was better than the volume of 0.57 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 60.10%.
During the past 100 days, Adc Therapeutics SA’s (ADCT) raw stochastic average was set at 62.33%, which indicates a significant increase from 36.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.47, while its 200-day Moving Average is $2.21. However, in the short run, Adc Therapeutics SA’s stock first resistance to watch stands at $3.00. Second resistance stands at $3.13. The third major resistance level sits at $3.28. If the price goes on to break the first support level at $2.72, it is likely to go to the next support level at $2.57. The third support level lies at $2.44 if the price breaches the second support level.
Adc Therapeutics SA (NYSE: ADCT) Key Stats
The company with the Market Capitalisation of 284.64 million has total of 99,178K Shares Outstanding. Its annual sales at the moment are 70,840 K in contrast with the sum of -157,850 K annual income. Company’s last quarter sales were recorded 23,030 K and last quarter income was -38,600 K.
